Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study
Keywords: Prostate cancer; Seed implantation; Quality of life; Palladium; Iodine; Cesium; Low-dose-rate; EPIC-50; Time-driven activity-based costing;